Radiofrequency Ablation for BIII Thyroid Nodules
Part of paid clinical trials in New York, New York.
- Sponsor
- Columbia University
- Study ID
- NCT05189808
- Status
- Recruiting
Conditions
- Indeterminate Bethesda III Thyroid Nodules
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Radiofrequency Ablation — PROCEDUREUltrasound guided radiofrequency ablation (non-experimental)
Study Details
The purpose of this observational chart review study is to evaluate the efficacy and safety of Radiofrequency Ablation (RFA) for treatment of indeterminate thyroid nodules before and after RFA procedure. This is a data collection study in which the investigators ask patients to give access to information generated before and after RFA treatment of their condition. The RFA procedure uses image guidance to place an electrode through the skin into the target area. In RFA, high-frequency electrical currents are passed through an electrode, creating a small region of heat to treat the lesion.
Key Dates
- Start date
- Aug 1, 2020
- Status verified
- May 2026
- Primary completion
- Aug 31, 2027
- Completion
- Aug 31, 2028
Study Design
- Enrollment
- 50 participants (estimated)
Arms
- Arm: Group
Primary Outcome Measure
Change in Nodule Volume [ Time Frame: 12 months ]
Central Contacts
- Jennifer H Kuo, MD MS212-305-6969
- Catherine McManus, MD MS212-305-6969
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Columbia University | New York | New York | 10032 |
Find similar trials in New York, NY
By research site